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o 4.6
Aortoiliac Disease-Endovascular Treatment
For a detailed discussion of endovascular treatment
of aortoiliac disease, see B 4.3.2, Aortoiliac PTA, p
583. Endovascular techniques such as PTA and stent
placement have the advantage of lower morbidity
and mortality risk compared with open surgical
revascularisations.' The death and complication
rates of aortoiliac PTA and stent placement were
analysed ' in a meta-analysis of 2,116 reported
patlents.? Death within hospital stay (not 30-day
mortality) averaged 0.14% for PTA and 0.3% for
stent procedures. The 30-day mortality rate aver-
aged 0.8% for PTA and 1.0% for stent procedures
(For detailed discussion of complications of
endovascular procedures, see B 4.3.7, P 5109). The
mean systemic complication rate was 1.3%; the local
complication rate, 9.6%; and the mean rate of major
complications necessitating treatment was 4.3% for
PTA and 5.2% for stents, respectively>
Endovascular procedures are generally performed
on patients with less severe disease than those
undergoing surgical treatment. The risk for endovas-
cular technique is much lower than for surgical
treatment. However, PTA and stents offer a lower
durability of the result as compared with bifurcated
graft surgery. The adjusted 4-year primary patency
rate for treatment of CLI, with technical failures
included, was 53% after PTA and 67% after stent
placement for the treatment of stenoses.s-' Analysis
of variables that could potentially affect the patency
results shown some heterogeneity. However, disease
severity (CLI vs claudication), lesion type (occlusion
vs stenosis), and lesion site (common vs external
iliac) were found to affect patency in some studies.v'
An analysis of the results of the endovascular
treatment of aortoiliac disease has already been pre-
sented (see B4.3.2, Aortoiliac PTA, p 583, and B 4.3.3,
Aortoiliac Stents, p 586) and is not repeated here.
This is because these procedures have been predom-
inantly performed for claudication (proportion of
patients undergoing procedures for claudication:
77% of PTA performed for iliac stenoses, 82% of iliac
PTA for occlusions, 78% of iliac stenting for stenosis,
and 86% of iliac stenting for occlusion). It should
therefore be pointed out, in reviewing these data in
comparison with the surgical bypass data presented
earlier (see D 4.5.3, P 5174), that the iliac PTA and
stent data primarily reflect the treatment of unilater-
al (iliac) disease, with lesions amenable to these
modalities.
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04.7
Introduction to Preferred Therapeutic Options
The decision about what type of revascularisation to
recommend ideally should be made by a multidisci-
plinary team. Important issues that may influence the
recommended decision are :
• lesion morphology
• risk of surgery for that particular patient
• previous procedures (ie, bypass or angioplasty)
• patient's life expectancy
• local expertise and experience with particular sur-
gical or endovascular procedures
In general, endovascular procedures are safer and
require shorter hospitalisation compared with surgical
procedures. Durability of these endovascular proce-
dures is, however, less well established. For most
lesions, there is no direct evidence comparing the
results of endovascular or surgical treatment in a con-
trolled, prospective, randomised study.
The system used for preferred therapeutic options
has been detailed (see B 4.3, Endovascular Procedures
for Intermittent Claudication, p 582). Lesions are
defined and then placed in four groups, each group
usually being treated in a similar way. The two
extremes are type A lesions, in which endovascular
approach is the treatment of choice, and type D
lesions, in which surgery is the treatment of choice . In
between these two groups are types Band C lesions, in
which no firm recommendations can be made about
the preferred interventional option. However,
endovascular treatment is more commonly used in
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type B lesions and surgical treatment is more com-
monly used in type C lesions. There is insufficient
solid evidence to make any firm recommendations,
particularly in the case of types Band C. Most patients
with CLI have multilevel disease, and it may be
appropriate to use different techniques for different
lesions.
04.7.1
Aortoiliac Disease-Preferred Therapeutic Options
The following and other similarly set out recommen-
dations merely consider the probable relative merits of
surgical and endovascular treatment, on the assump-
tion that intervention is desirable. It is therefore iden-
tical to Recommendation 31 (p 583). The final choice of
intervention, particularly for category 2 and 3 lesions,
will of course depend on a number of other consider-
ations, such as the patient's overall health, the severi-
ty of the local lesion, etc.
Repeated front p 583
Recommendation 31: MorpllOlogicalstrat(ficatioll of
iliac lesiolls
TASC Type A iliac lesions:
1. Single stenosis <3 em of the CIA or EIA (uni-
laterallbila teral)
TASC Type B iliac lesions:
2. Single stenosis 3-10 em iu lengtlt.not extending
into the common femoral artenj (CFA)
3. Total of two stenoses <5cm long in the CIA
and/or EIA and not extending into the CFA
4. Unilateral CIA occlusion
TASC Type C iliac lesions:
5. Bilateral 5-10-cm-long stenoses of the CIA
audlor EIA, not extending into the CFA
6. Unilateral EIA occlusion not extending into
the CFA
7. Unilateral EIA stenosis extending into the CFA
8. Bilateral CIA occlusion
TASC Type D iliac lesions:
9. Diffuse, multiple unilateral stenoses involving
the CIA, EIA, and CFA (usually >10cm)
10. Unilateral occlusion involving both the CIA
and EIA
11.Bilateral EIA occlusions
12. Diffuse disease iuuoluing the aorta and both
iliac arteries
13. Iliac stenoses ill a patient toith all abdominal
aortic aneurysm or other lesion requiring aor-
tic or iliac surgen)
Abbreoiations: CIA, CO/II/1l01l iliac artery; EIA, external
iliac artery; CFA, COmll101l femoral artery.
Repeated from p 583
Recommendation 32: Treatment of choice for TASC~ ;
time A and D aortoiliac lesions
C>~
Endouascular procedureis the treatment ofchoicefor
type A lesions and surgen) is the procedure of choice
for type D lesions.
Repeated from p 583
Critical Issue 10: Treatment of TASC tune B and C~ c~
lesions
More evidence is needed to make allY firm recoin-
mendations about the best treatment for TA5C types
Band C lesions.*
*CIR5E dissenting opinion:
Curreutlyendotiascular treatment is more cOlllmollly used
for type B and C lesions, but more eoidence is needed to
make allYfirm recommendations about best treatment.
Reason for disselltillg suiukuu Due to technical develop-
menis, type C lesions of iliac andfemoral arteries call be
treated by endouasculnr means toitha reasonable technical
success rate (for references, see B 4.3), Therefore, CIR5E
believes that ill clinical practice these lesions are more
comnionlu treated by endooasular techniques, althoug):
scientific eoidence ofallY superiority overvascular surgery
is lacking.
o 4.7.2
Combined Surgical and Endovascular Procedures
This discussion primarily concerns the choice between
open surgical reconstruction and endovascular proce-
dures and is directed toward proximal revascularisa-
tion. The common occurrence of multilevel disease in
CLI patients has already been alluded to and dis-
cussed in terms of the need for concomitant distal
bypass. However, combinations of endovascular and
surgical procedures are increasingly being employed.
Combined endovascular/surgical procedures have
had some success in this regard. In considering the
approach to a combined procedure, either concurrent-
ly in the operating room or sequentially in the angiog-
raphy suite with early subsequent bypass, each lesion
must be considered on its own merit. Iliac artery
dilatation to improve inflow for a cross-femoral graft
has been reported to be successful in carefully selected
patients.J.2 Those patients with pressure gradients
across aortoiliac stenoses should have these corrected
before construction of a distal bypass graft.
For suitable lesions, balloon angioplasty, performed
either intraoperatively or preoperatively, provides
adequate inflow to maintain the distal reconstruction.
The quality of the endovascular and surgical cornpo-
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nents of the technique must not be compromised by
skills and training of the individual performing either
part of the procedure. Also, in the absence of sufficient
length of ideal conduit for a distal bypass, balloon
angioplasty may remove a discrete lesion distally, per-
mitting longer-term patency of an otherwise compro-
mised graft. The determination of combining or per-
forming the procedures sequentially will be deter-
mined by local circumstances.
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D4.8
Infrainguinal Disease-Surgical Treatment
The main guiding principles behind surgical recon-
struction are to bypass into the best available outflow
vessel possible regardless of the anatomic level and to
construct the bypass graft with autogenous vein.
Further explanation and exceptions to these principles
are discussed in the following sections. The issue of
aboue-knec femoropoplitcal bypass grafting has been
addressed earlier (see B 4.4, Surgery for Intermittent
Claudication, p 597). When a bypass graft is con-
structed to an outflow artery below the knee, autoge-
nous tissue is accepted as the preferred conduit.
04.8.1
Inflow
Before reconstruction of infrainguinal PAD, the sur-
geon must ensure adequate inflow to the groin level or
site of proximal anastomosis (see also
Recommendation 88, p 5178). The common femoral
artery or an inflow graft is the usually accepted origin
of a femoral distal bypass graft. A number of authors
have reviewed experience with more distal take-off of
bypass grafts (profunda, SFA, popliteal) and have
found that in appropriately chosen individuals there
is no compromise to the bypass.t-e For example, a
stenosis of 20% or more in the native superficial
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femoral artery proximal to a graft origin has been cor-
related with eventual graft failure.' Because athero-
sclerosis is a generalised and in many cases progres-
sive disease, distal origin bypass grafts should be
undertaken only when inflow to that level is uncom-
promised. This issue is of some importance when
alternative (and presumably shorter) segments of vein
must be used for bypass grafts.
Recommendation 89: Inflow artery for femorodistal
bypass
Any artery, regardless of level (ie, not only the com-
mon femoral artery), may serve as an inflow artery
for a distal bypass provided that flow to that artery
and the origin of the graft is uncompromised.
o 4.8.2
Outflow (Run-off) Arteries
The guiding principle here is to choose the distal out-
flow artery that allows the best perfusion of the foot.
Any distal artery, including the pedal arteries, may
serve as a suitable outflow tract with acceptable
expected patency rates.t- The results of
femora-below-knee popliteal grafting are similar to
femoral distal bypass grafting. The choice of the site of
the distal anastomosis should be based on the quality
of the distal artery and its runoff and not the length of
the bypass. The main exceptions to this relate to the
lack of adequate length of suitable vein.
04.8.3
Distal Bypass Grafts
The same principles as outlined in the previous sec-
tion on femoral-popliteal lesions apply to more distal
bypass grafts. The increased length of the required
conduit introduces some special problems in the
absence of long saphenous vein, and these arc dis-
cussed in the following sections. There should be no
effort to compromise the length of bypass just to have
the distal anastomosis in the popliteal artery rather
than a distal artery. The best distal artery should be
selected, because this will give the best long-term
patency rates.
Recommendation 90: Femorofemoral distal bypass
outflow vessel
In a femoral crural bypass, the least diseased distal
artery with the best continuous run-off to the
ankle/foot should be used for outflow regardless of
location, provided there is adequate length of suit-
able vein.
